Skip to main content

Alex Howarth

Equibles does not estimate personal net worth.

Get an email with a short summary when Altimmune, Inc. publishes a filing, an earnings call transcript or a press release.

Get ALT alerts

About Alex Howarth

Alex Howarth is recorded as Board Member at Altimmune, Inc. (ALT) since November 2, 2026. Altimmune, Inc. reported in an 8-K filed October 27, 2026 that Alex Howarth was appointed director of the Board, effective November 2, 2026. Altimmune, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Altimmune, Inc. includes Jerome Durso (CEO and Board Member), Vipin K. Garg (CEO), William Enright (CEO) and 7 others.

“On October 23, 2026, the Board of Directors, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Peter Greenleaf and Alex Howarth as directors of the Board effective November 2, 2026, and approved an increase in its size from nine to eleven directors.”
Altimmune, Inc. Form 8-K, filed October 27, 2026 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2026-11-02–present

Leadership on record at Altimmune, Inc.

Recent activity